文献速递类风湿关节炎

学习协作组织促进类风湿关节炎达标治疗实施的效果与可持续性:一项整群随机对照II期临床试验结果

Benefits and Sustainability of a Learning Collaborative for Implementation of Treat-to-Target in Rheumatoid Arthritis: Results of a Cluster-Randomized Controlled Phase II Clinical Trial.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2018-01-01

该II期整群随机对照试验从11个风湿科站点招募636例类风湿关节炎患者,评估学习协作组织促进达标治疗实施的效果。干预后达标治疗实施评分从基线11%升至57%(I期干预站点),等待对照组从13%升至58%;I期干预站点在II期维持改善(52%)。结论认为达标治疗改善在干预后期间保持相对稳定。

要点

  • 学习协作组织可使类风湿关节炎达标治疗实施评分从基线约11%–13%提升至57%–58%。
  • I期干预站点在II期维持改善,达标治疗实施评分为52%。
  • 站点仅含风湿科医生、学术隶属、每站点医生较少及风湿科医生为受训者与更大改善相关。

核心结论

  • 达标治疗的改善在干预后期间保持相对稳定。

研究设计与样本

  • 两阶段随机对照试验,从11个风湿科站点招募患者,随机分为I期接受学习协作组织干预组或II期接受干预的等待对照组。
  • 分析纳入636例类风湿关节炎患者,结局为达标治疗实施评分(0–100,100为最佳)从干预前至干预后的变化。
  • 达标治疗实施评分定义为就诊记录中记录的组成部分百分比。

主要发现

  • 基线时,I期干预站点平均达标治疗实施评分为11%,II期站点为13%。
  • 干预后,I期干预站点达标治疗实施评分改善至57%,II期站点改善至58%。
  • I期干预站点在II期维持改善,评分为52%。
  • 达标治疗改善更大的预测因素包括:站点仅有风湿科医生、站点有学术隶属、每站点医生较少、风湿科医生为受训者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We conducted a 2-phase randomized controlled trial of a learning collaborative to facilitate implementation of treat-to-target (T2T) to manage rheumatoid arthritis (RA). We found substantial improvement in implementation of T2T in phase I. Here, we report on a second 9 months (phase II), where we examined the maintenance of response in phase I and predictors of greater improvement in T2T adherence. METHODS: We recruited patients from 11 rheumatology sites and randomized them to either receive the learning collaborative during phase I or to a wait-list control group that received the learning collaborative intervention during phase II. The outcome was change in T2T implementation score (0-100, where 100 = best) from pre- to postintervention. The T2T implementation score was defined as a percent of components documented in visit notes. Analyses examined the extent to which the phase-I intervention teams sustained improvement in T2T, as well as predictors of T2T improvement. RESULTS: The analysis included 636 RA patients. At baseline, the mean T2T implementation score was 11% in phase I intervention sites and 13% in phase II sites. After the intervention, T2T implementation score improved to 57% in the phase I intervention sites and to 58% in the phase II sites. Intervention sites from phase I sustained the improvement during the phase II (52%). Predictors of greater T2T improvement included having only rheumatologist providers at the site, academic affiliation of the site, having fewer providers per site, and the rheumatologist provider being a trainee. CONCLUSION: Improvement in T2T remained relatively stable over a postintervention period.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Solomon DH, Lu B, Yu Z, et al. Benefits and Sustainability of a Learning Collaborative for Implementation of Treat-to-Target in Rheumatoid Arthritis: Results of a Cluster-Randomized Controlled Phase II Clinical Trial. Arthritis Care Res (Hoboken). 2018. PMID: 29316341. doi:10.1002/acr.23508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。